
CASI Pharmaceuticals CASI
Quartalsbericht 2022-Q3
hinzugefügt 14.11.2022
CASI Pharmaceuticals Current Ratio 2011-2026 | CASI
Current Ratio Jährlich CASI Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 4.56 | 9.28 | 7.74 | 23.9 | 8.65 | 20.9 | 5.29 | 12 | 27.3 | 12 | 4.55 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 27.3 | 4.55 | 12.4 |
Current Ratio Vierteljährlich CASI Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 2.86 | 4.06 | 4.2 | 4.56 | 5.09 | 5.35 | 5.72 | 5.29 | 5.29 | 5.29 | 5.29 | 11.4 | 11.4 | 11.4 | 11.4 | 28.7 | 28.7 | 28.7 | 28.7 | 6.87 | 6.87 | 6.87 | 6.87 | 4 | 4 | 4 | 4 | 0.49 | 0.49 | 0.49 | 0.49 | 0.96 | 0.96 | 0.96 | 0.96 | 27.4 | 27.4 | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 28.7 | 0.49 | 8.59 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
3.48 | $ 3.56 | - | $ 1.06 B | ||
|
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M | ||
|
Advaxis
ADXS
|
5.93 | - | -9.65 % | $ 45.9 M | ||
|
AC Immune SA
ACIU
|
1.95 | $ 3.13 | - | $ 229 M | ||
|
I-Mab
IMAB
|
8.96 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | ||
|
AgeX Therapeutics
AGE
|
1.81 | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | ||
|
Albireo Pharma
ALBO
|
2.39 | - | -0.23 % | $ 916 M | ||
|
Aileron Therapeutics
ALRN
|
7.98 | - | 10.36 % | $ 9.8 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | ||
|
ADC Therapeutics SA
ADCT
|
1.2 | $ 4.22 | - | $ 105 M | ||
|
Aptorum Group Limited
APM
|
3.71 | $ 0.79 | 0.01 % | $ 4.31 M | ||
|
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M | ||
|
argenx SE
ARGX
|
8.81 | $ 703.3 | - | $ 25 B | ||
|
Adverum Biotechnologies
ADVM
|
1.65 | - | - | $ 86.2 M | ||
|
Ascendis Pharma A/S
ASND
|
0.889 | $ 231.03 | 2.23 % | $ 5 B | ||
|
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.61 | - | $ 8.69 B | ||
|
Atea Pharmaceuticals
AVIR
|
7.92 | $ 6.05 | - | $ 493 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | ||
|
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
4.74 | $ 6.63 | - | $ 182 M | ||
|
BioCardia
BCDA
|
0.651 | $ 1.27 | - | $ 26.9 M | ||
|
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - | ||
|
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | ||
|
Athersys
ATHX
|
2.38 | - | 3.77 % | $ 22.4 M | ||
|
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | ||
|
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | ||
|
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | ||
|
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | ||
|
Aeterna Zentaris
AEZS
|
1.6 | - | 5.93 % | $ 314 M | ||
|
AlloVir
ALVR
|
22.6 | - | 4.14 % | $ 49.1 M | ||
|
Catalyst Biosciences
CBIO
|
6.97 | $ 11.58 | - | $ 1.03 B | ||
|
Cerus Corporation
CERS
|
1.41 | $ 1.8 | 6.51 % | $ 343 M | ||
|
Anika Therapeutics
ANIK
|
14.4 | $ 14.36 | - | $ 210 M | ||
|
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | ||
|
BioNTech SE
BNTX
|
7.95 | $ 90.54 | - | $ 27.2 B | ||
|
Aptose Biosciences
APTO
|
0.69 | - | -45.71 % | $ 1.2 M | ||
|
Burford Capital Limited
BUR
|
2.14 | $ 8.05 | - | $ 1.34 B | ||
|
AVEO Pharmaceuticals
AVEO
|
1.77 | - | - | $ 521 M | ||
|
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M | ||
|
CNS Pharmaceuticals
CNSP
|
3.45 | $ 2.45 | 0.41 % | $ 936 K | ||
|
Aytu BioScience
AYTU
|
1.47 | $ 2.64 | - | $ 16.6 M | ||
|
Cardiff Oncology
CRDF
|
3.75 | $ 1.9 | - | $ 127 M | ||
|
CorMedix
CRMD
|
1.96 | $ 6.54 | - | $ 471 K | ||
|
Avenue Therapeutics
ATXI
|
3.27 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
2.2 | $ 1.51 | - | $ 385 M |